• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study.脓毒性休克中替代复苏策略、宿主反应与损伤生物标志物之间的关系及预后:早期脓毒性休克基于方案治疗的分析
Crit Care Med. 2017 Mar;45(3):438-445. doi: 10.1097/CCM.0000000000002206.
2
Biomarker response to drotrecogin alfa (activated) in children with severe sepsis: results from the RESOLVE clinical trial*.儿童严重脓毒症中对活化的凝血酶原复合物(drotrecogin alfa)的生物标志物反应:RESOLVE 临床试验的结果*。
Pediatr Crit Care Med. 2012 Nov;13(6):639-45. doi: 10.1097/PCC.0b013e318250ad48.
3
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.以外周灌注状态为目标的复苏策略与血清乳酸水平对感染性休克患者 28 天死亡率的影响:ANDROMEDA-SHOCK 随机临床试验。
JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.
4
Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.严重脓毒症和脓毒性休克患者外源性凝血途径的激活。
Crit Care Med. 1998 Dec;26(12):2005-9. doi: 10.1097/00003246-199812000-00030.
5
Mortality rate among patients with septic shock after implementation of 6-hour sepsis protocol in the emergency department of Thammasat University Hospital.泰国国立法政大学医院急诊科实施6小时脓毒症治疗方案后脓毒性休克患者的死亡率
J Med Assoc Thai. 2014 Aug;97 Suppl 8:S182-93.
6
The Effects of Alternative Resuscitation Strategies on Acute Kidney Injury in Patients with Septic Shock.替代复苏策略对感染性休克患者急性肾损伤的影响
Am J Respir Crit Care Med. 2016 Feb 1;193(3):281-7. doi: 10.1164/rccm.201505-0995OC.
7
Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial.脓毒症休克中的内皮通透性与止血:ProCESS试验结果
Chest. 2017 Jul;152(1):22-31. doi: 10.1016/j.chest.2017.01.010. Epub 2017 Jan 19.
8
Central venous-to-arterial carbon dioxide partial pressure difference in early resuscitation from septic shock: a prospective observational study.脓毒性休克早期复苏中中心静脉与动脉血二氧化碳分压差值:一项前瞻性观察性研究
Eur J Anaesthesiol. 2014 Jul;31(7):371-80. doi: 10.1097/EJA.0000000000000064.
9
[Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and pro-inflammatory cytokines in patients with refractory septic shock].[研究高容量血液滤过和液体复苏对难治性感染性休克患者血乳酸及促炎细胞因子清除的影响]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jul;21(7):421-4.
10
Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial.硝酸甘油对严格复苏方案后严重脓毒症/脓毒性休克患者舌下微循环血流的影响:一项双盲随机安慰剂对照试验。
Crit Care Med. 2010 Jan;38(1):93-100. doi: 10.1097/CCM.0b013e3181b02fc1.

引用本文的文献

1
Efficacy and prognostic analysis of the oXiris® filter in sepsis-associated acute kidney injury.oXiris®滤器在脓毒症相关性急性肾损伤中的疗效及预后分析
Int Urol Nephrol. 2025 Apr 24. doi: 10.1007/s11255-025-04533-y.
2
Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review.脓毒症相关急性肺损伤的早期识别与诊断、病理生理学及治疗:一篇叙述性综述
J Thorac Dis. 2024 Aug 31;16(8):5457-5476. doi: 10.21037/jtd-24-1191. Epub 2024 Aug 28.
3
Patterns of inflammatory immune responses in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: clustering analysis in Korea.接受维生素C、氢化可的松和硫胺素治疗的感染性休克患者的炎症免疫反应模式:韩国的聚类分析
Acute Crit Care. 2023 Aug;38(3):286-297. doi: 10.4266/acc.2023.00507. Epub 2023 Aug 21.
4
Association between the volume of fluid resuscitation and mortality modified by disease severity in patients with sepsis in ICU: a retrospective cohort study.在 ICU 中患有脓毒症的患者中,液体复苏量与死亡率的关系受疾病严重程度的影响:一项回顾性队列研究。
BMJ Open. 2023 Apr 11;13(4):e066056. doi: 10.1136/bmjopen-2022-066056.
5
Rationale for sequential extracorporeal therapy (SET) in sepsis.序贯体外治疗(SET)在脓毒症中的应用原理。
Crit Care. 2023 Feb 7;27(1):50. doi: 10.1186/s13054-023-04310-2.
6
Discrepancy of C-Reactive Protein, Procalcitonin and Interleukin-6 at Hospitalization: Infection in Patients with Normal C-Reactive Protein, Procalcitonin and High Interleukin-6 Values.住院时C反应蛋白、降钙素原和白细胞介素-6的差异:C反应蛋白和降钙素原正常但白细胞介素-6值高的患者中的感染
J Clin Med. 2022 Dec 9;11(24):7324. doi: 10.3390/jcm11247324.
7
Urinary Cysteinyl Leukotrienes as Biomarkers of Endothelial Activation, Inflammation and Oxidative Stress and Their Relationship with Organ Dysfunction in Human Septic Shock.尿半胱氨酰白三烯作为内皮细胞活化、炎症和氧化应激的生物标志物及其与人类脓毒症休克器官功能障碍的关系
Biomedicines. 2022 Nov 8;10(11):2845. doi: 10.3390/biomedicines10112845.
8
Effect of Fluid Resuscitation Strategies for Obese Patients with Sepsis and Septic Shock: A Systematic Review.肥胖脓毒症和脓毒性休克患者液体复苏策略的效果:一项系统评价
Intensive Care Res. 2023;3(1):61-68. doi: 10.1007/s44231-022-00019-y. Epub 2022 Oct 27.
9
Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy.脓毒症相关性脑病中调节性T细胞的研究进展
Front Neurol. 2022 Mar 16;13:830784. doi: 10.3389/fneur.2022.830784. eCollection 2022.
10
Subtypes and Mimics of Sepsis.败血症的亚型和类似疾病。
Crit Care Clin. 2022 Apr;38(2):195-211. doi: 10.1016/j.ccc.2021.11.013.

本文引用的文献

1
Early goal-directed therapy: do we have a definitive answer?早期目标导向治疗:我们有明确的答案了吗?
Intensive Care Med. 2016 Jun;42(6):1048-50. doi: 10.1007/s00134-016-4295-6. Epub 2016 Mar 7.
2
Trial of early, goal-directed resuscitation for septic shock.早期目标导向性复苏治疗脓毒性休克的试验。
N Engl J Med. 2015 Apr 2;372(14):1301-11. doi: 10.1056/NEJMoa1500896. Epub 2015 Mar 17.
3
Goal-directed resuscitation for patients with early septic shock.目标导向性复苏治疗早期感染性休克患者。
N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.
4
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.2000-2012 年澳大利亚和新西兰重症监护病房严重脓毒症和脓毒性休克患者的死亡率。
JAMA. 2014 Apr 2;311(13):1308-16. doi: 10.1001/jama.2014.2637.
5
A randomized trial of protocol-based care for early septic shock.一项基于方案的早期脓毒性休克护理的随机试验。
N Engl J Med. 2014 May 1;370(18):1683-93. doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18.
6
Severe sepsis and septic shock.严重脓毒症和脓毒性休克。
N Engl J Med. 2013 Aug 29;369(9):840-51. doi: 10.1056/NEJMra1208623.
7
Inflammation, endothelium, and coagulation in sepsis.脓毒症中的炎症、内皮与凝血
J Leukoc Biol. 2008 Mar;83(3):536-45. doi: 10.1189/jlb.0607373. Epub 2007 Nov 21.
8
The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock.早期血流动力学优化对严重脓毒症和脓毒性休克生物标志物模式的影响。
Crit Care Med. 2007 Sep;35(9):2016-24. doi: 10.1097/01.ccm.0000281637.08984.6e.
9
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.了解肺炎和脓毒症中的炎性细胞因子反应:脓毒症基因与炎性标志物(GenIMS)研究结果
Arch Intern Med. 2007;167(15):1655-63. doi: 10.1001/archinte.167.15.1655.
10
Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia.等渗预水化可使人类内毒素血症中的细胞因子反应朝着更具抗炎性的平衡转变。
J Endotoxin Res. 2005;11(5):287-93. doi: 10.1179/096805105X58715.

脓毒性休克中替代复苏策略、宿主反应与损伤生物标志物之间的关系及预后:早期脓毒性休克基于方案治疗的分析

Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study.

作者信息

Kellum John A, Pike Francis, Yealy Donald M, Huang David T, Shapiro Nathan I, Angus Derek C

机构信息

1Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA. 2Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA. 3Department of Emergency Medicine, The Beth Israel Hospital, Harvard University, Boston, MA.

出版信息

Crit Care Med. 2017 Mar;45(3):438-445. doi: 10.1097/CCM.0000000000002206.

DOI:10.1097/CCM.0000000000002206
PMID:28079606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5448291/
Abstract

OBJECTIVES

The Protocol-based Care for Early Septic Shock trial found no differences across alternative resuscitation strategies in all-cause mortality. A separate aim was to determine whether differences in resuscitation strategies affected trajectories of biomarkers of key pathways associated with downstream clinical outcomes of sepsis and whether there were differences in survival across treatment arms for patients with different baseline biomarker profiles.

DESIGN

Secondary analysis of a large randomized clinical trial.

SETTING

Thirty-one U.S. hospitals.

PATIENTS

Six hundred twenty-eight patients with septic shock.

INTERVENTIONS

Two resuscitation protocols versus usual care.

MEASUREMENTS AND MAIN RESULTS

We measured a panel of biomarkers representing four pathophysiologic domains: "inflammation" (tumor necrosis factor, interleukin-6, and -10); "coagulation" (D-dimers, thrombin-antithrombin complex); "oxidative stress" (urine isoprostane); and "tissue hypoxia" (lactate) at 0, 6, 24, and 72 hours after treatment. We analyzed whether alternative resuscitation strategies affected biomarker trajectories over 72 hours and whether effects on 90-day hospital mortality varied by baseline (time 0) biomarker profiles-both using regression models with interaction terms for treatment arms. For all baseline biomarkers, higher concentrations were associated with increased risk of death by 90 days. However, there was no significant effect of treatment assignment on subsequent biomarker trajectories. We did find evidence for heterogeneity of treatment effect of protocol-based care on mortality for patients with different baseline [interleukin-6] and [interleukin-6] × [interleukin-10] profiles, whereas patients with the lowest quartiles fared better with protocol-based care (odds ratios, 0.32 [0.13-075]; p = 0.01 and 0.32 [0.14-0.73]; p = 0.01, respectively).

CONCLUSIONS

In patients with septic shock, alterations in inflammation, coagulation, oxidative stress, and tissue hypoxia are common and associated with adverse outcomes but are not influenced by protocol-based resuscitation compared with usual care. However, contrary to expectation, protocol-based resuscitation appeared to be superior in patients with lower concentrations of inflammatory biomarkers. The mechanisms responsible for this effect are unclear.

摘要

目的

基于方案的早期脓毒性休克治疗试验发现,不同复苏策略在全因死亡率方面并无差异。另一个目的是确定复苏策略的差异是否会影响与脓毒症下游临床结局相关的关键通路生物标志物的变化轨迹,以及不同基线生物标志物特征的患者在各治疗组中的生存情况是否存在差异。

设计

对一项大型随机临床试验进行二次分析。

地点

美国31家医院。

患者

628例脓毒性休克患者。

干预措施

两种复苏方案与常规治疗。

测量指标及主要结果

我们在治疗后0、6、24和72小时测量了一组代表四个病理生理领域的生物标志物:“炎症”(肿瘤坏死因子、白细胞介素-6和-10);“凝血”(D-二聚体、凝血酶-抗凝血酶复合物);“氧化应激”(尿异前列腺素);以及“组织缺氧”(乳酸)。我们分析了不同的复苏策略是否会在72小时内影响生物标志物的变化轨迹,以及对90天医院死亡率的影响是否因基线(0时)生物标志物特征而异——两者均使用带有治疗组交互项的回归模型。对于所有基线生物标志物,较高浓度与90天内死亡风险增加相关。然而,治疗分配对随后的生物标志物变化轨迹没有显著影响。我们确实发现,对于具有不同基线[白细胞介素-6]和[白细胞介素-6]×[白细胞介素-10]特征的患者,基于方案的治疗在死亡率方面存在治疗效果异质性,而四分位数最低的患者接受基于方案的治疗效果更好(优势比分别为0.32[0.13 - 0.75];p = 0.01和0.32[0.14 - 0.73];p = 0.01)。

结论

在脓毒性休克患者中,炎症、凝血、氧化应激和组织缺氧的改变很常见且与不良结局相关,但与常规治疗相比,基于方案的复苏并未对其产生影响。然而,与预期相反,基于方案的复苏在炎症生物标志物浓度较低的患者中似乎更具优势。造成这种效果的机制尚不清楚。